Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
Inhaled Nitrite in Subjects With Pulmonary Hypertension
† Study has passed its completion date and status has not been verified in more than two years.